"Southwest General is home to nationally recognized physicians, state-of-the-art technology and a full range of medical, surgical and emergency services, including a Level III trauma center. Our services are designed to provide patients with care that addresses their physical, mental, emotional and spiritual needs."

During the past decade, Southwest General Health Center Ireland Cancer Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 16 clinical trials were completed, i.e. on average, 533.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest General Health Center Ireland Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest General Health Center Ireland Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Southwest General Health Center Ireland Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Prostate Cancer" (3 trials), "ATM Gene Mutation" (1 trials) and "ATR Gene Mutation" (1 trials). Many other conditions were trialed in "Southwest General Health Center Ireland Cancer Center" in a lesser frequency.

Most popular intervention types in "Southwest General Health Center Ireland Cancer Center" are "Drug" (16 trials), "Other" (11 trials), "Biological" (10 trials), "Radiation" (7 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "FGFR Inhibitor AZD4547" (2 trials) and "Ipilimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southwest General Health Center Ireland Cancer Center" are 15 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Southwest General Health Center Ireland Cancer Center". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Southwest General Health Center Ireland Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest General Health Center Ireland Cancer Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".